The prevalence of inflammatory bowel disease (IBD) in patients with PSC differs in various
part of the world. Ulcerative colitis (UC) is most common, but 1 to 14% of all primary …

Diseases involving the hepatopancreatobiliary (HPB) system are frequently encountered in
patients with inflammatory bowel disease (IBD). Hepatobiliary manifestations constitute …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

These guidelines on the management of primary sclerosing cholangitis (PSC) were
commissioned by the British Society of Gastroenterology liver section. The guideline writing …

Background Primary sclerosing cholangitis (PSC) is strongly associated with inflammatory
bowel disease (IBD). The aim of this study was to assess the IBD phenotype associated with …

Abstract Background & Aims The association between primary sclerosing cholangitis (PSC)
and inflammatory bowel disease (IBD) is well recognised. However, the relationship …

Inflammatory bowel diseases are associated with various hepatobiliary disorders, reported
both in Crohn's disease and ulcerative colitis. They may occur at any moment in the natural …

Primary sclerosing cholangitis (PSC) is a chronic progressive disorder of unknown aetiology
characterised by chronic inflammation and stricture formation of the biliary tree. Symptoms …

Nearly a century ago, jaundiced patients were observed to have surprising and
spontaneous remissions from incurable immunologic diseases including rheumatoid …

Liver transplantation (LT) is the only therapeutic option for end‐stage primary sclerosing
cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study …